Mankind Pharma Limited has informed the Exchange about Credit Rating
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mankind Pharma received credit rating updates from ICRA Limited for three instruments. The company maintained its strong AA+ (Stable) rating for long-term debt and NCDs worth ₹6,250 crore combined. A fresh A1+ rating was assigned to ₹600 crore Commercial Paper programme. All ratings carry a stable outlook, indicating no immediate concerns about the company's debt servicing capability. The reaffirmation reflects continued financial stability of the pharma manufacturer.
Strong credit ratings above AA are positive for existing bondholders and indicate low default risk. The stable outlook suggests no near-term pressure on the company's borrowing costs or access to capital markets.